TEVA
NYSE
$31
Teva- Pharmaceutical Industries Ltd (TEVA)
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic drugs, specialty drugs, and biopharmaceuticals in North America, Europe, and internationally. The company is headquartered in Petach Tikva, Israel.
Sector:
Healthcare
Strong Buy
Target: $40.90 (+31.94%)
Market Cap
$36B
PEG Ratio
0.90
Forward P/E
15.43
P/E Ratio
27.91
Price Chart
Valuation
Market Cap$36B
P/E27.91
Forward P/E15.43
PEG0.90
P/S2.16
P/B4.47
Profitability
Total Revenue (TTM)$17B
Gross Profit (TTM)$9.03B
EBITDA$3.29B
Profit Margin9.3%
Operating Margin16.4%
EPS$1.13
Financial Health
Debt-to-Equity31.6%
Free Cash Flow Yield4.70%
Growth & Risk
Revenue 5Y CAGR+1.28%
Dividends 5Y CAGR+4.96%
Beta (5Y)0.83
Sharpe Ratio1.72